89 related articles for article (PubMed ID: 20651083)
1. A single-tube, sensitive multiplex method for screening of isocitrate dehydrogenase 1 (IDH1) mutations.
Chou WC; Huang YN; Huang CF; Tseng MH; Tien HF
Blood; 2010 Jul; 116(3):495-6. PubMed ID: 20651083
[No Abstract] [Full Text] [Related]
2. Characterization of IDH1 p.R132H Mutant Clones Using Mutation-specific Antibody in Myeloid Neoplasms.
Kurt H; Bueso-Ramos CE; Khoury JD; Routbort MJ; Kanagal-Shamanna R; Patel UV; Jorgensen JL; Wang SA; Ravandi F; DiNardo C; Luthra R; Medeiros LJ; Patel KP
Am J Surg Pathol; 2018 May; 42(5):569-577. PubMed ID: 29635257
[TBL] [Abstract][Full Text] [Related]
3. IDH1 and IDH2 mutation analysis in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome.
Lin J; Yao DM; Qian J; Chen Q; Qian W; Li Y; Yang J; Wang CZ; Chai HY; Qian Z; Xiao GF; Xu WR
Ann Hematol; 2012 Apr; 91(4):519-25. PubMed ID: 21997850
[TBL] [Abstract][Full Text] [Related]
4. Rapid and reliable detection of IDH1 R132 mutations in acute myeloid leukemia using high-resolution melting curve analysis.
Lin J; Qian J; Yao DM; Li Y; Yang J; Chen Q; Chai HY; Xiao GF; Xu WR
Clin Biochem; 2011 Jul; 44(10-11):779-83. PubMed ID: 21539821
[TBL] [Abstract][Full Text] [Related]
5. Isocitrate dehydrogenase mutations in myeloid malignancies.
Medeiros BC; Fathi AT; DiNardo CD; Pollyea DA; Chan SM; Swords R
Leukemia; 2017 Feb; 31(2):272-281. PubMed ID: 27721426
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of IDH1 mutations identified with PCR-RFLP assay in acute myeloid leukemia patients.
Elsayed GM; Nassar HR; Zaher A; Elnoshokaty EH; Moneer MM
J Egypt Natl Canc Inst; 2014 Mar; 26(1):43-9. PubMed ID: 24565682
[TBL] [Abstract][Full Text] [Related]
7. Novel multiplex bead-based assay for detection of IDH1 and IDH2 mutations in myeloid malignancies.
Shivarov V; Ivanova M; Hadjiev E; Naumova E
PLoS One; 2013; 8(9):e76944. PubMed ID: 24098815
[TBL] [Abstract][Full Text] [Related]
8. Differential prognostic effect of IDH1 versus IDH2 mutations in myelodysplastic syndromes: a Mayo Clinic study of 277 patients.
Patnaik MM; Hanson CA; Hodnefield JM; Lasho TL; Finke CM; Knudson RA; Ketterling RP; Pardanani A; Tefferi A
Leukemia; 2012 Jan; 26(1):101-5. PubMed ID: 22033490
[TBL] [Abstract][Full Text] [Related]
9. Rapid identification of IDH1 and IDH2 mutations in acute myeloid leukaemia using high resolution melting curve analysis.
Noordermeer SM; Tönnissen E; Vissers I; van der Heijden A; van de Locht LT; Deutz-Terlouw PP; Marijt EW; Jansen JH; van der Reijden BA
Br J Haematol; 2011 Feb; 152(4):493-6. PubMed ID: 20955413
[No Abstract] [Full Text] [Related]
10. Detection of isocitrate dehydrogenase 1 mutation R132H in myelodysplastic syndrome by mutation-specific antibody and direct sequencing.
Andrulis M; Capper D; Luft T; Hartmann C; Zentgraf H; von Deimling A
Leuk Res; 2010 Aug; 34(8):1091-3. PubMed ID: 20227112
[TBL] [Abstract][Full Text] [Related]
11. IDH1 and IDH2 mutations in therapy-related myelodysplastic syndrome and acute myeloid leukemia are associated with a normal karyotype and with der(1;7)(q10;p10).
Westman MK; Pedersen-Bjergaard J; Andersen MT; Andersen MK
Leukemia; 2013 Apr; 27(4):957-9. PubMed ID: 23192014
[No Abstract] [Full Text] [Related]
12. IDH mutations and trisomy 8 in myelodysplastic syndromes and acute myeloid leukemia.
Caramazza D; Lasho TL; Finke CM; Gangat N; Dingli D; Knudson RA; Siragusa S; Hanson CA; Pardanani A; Ketterling RP; Tefferi A
Leukemia; 2010 Dec; 24(12):2120-2. PubMed ID: 20861910
[No Abstract] [Full Text] [Related]
13. The prognostic significance of IDH1 mutations in younger adult patients with acute myeloid leukemia is dependent on FLT3/ITD status.
Green CL; Evans CM; Hills RK; Burnett AK; Linch DC; Gale RE
Blood; 2010 Oct; 116(15):2779-82. PubMed ID: 20651067
[TBL] [Abstract][Full Text] [Related]
14. [Detection of the IDH1 gene mutation in acute myeloid leukemia by PCR-high resolution melting analysis].
Lin J; Qian J; Yao DM
Zhonghua Xue Ye Xue Za Zhi; 2011 Jul; 32(7):484-6. PubMed ID: 22213873
[No Abstract] [Full Text] [Related]
15. Comparison of immunohistochemistry, DNA sequencing and allele-specific PCR for the detection of IDH1 mutations in gliomas.
Loussouarn D; Le Loupp AG; Frenel JS; Leclair F; Von Deimling A; Aumont M; Martin S; Campone M; Denis MG
Int J Oncol; 2012 Jun; 40(6):2058-62. PubMed ID: 22447191
[TBL] [Abstract][Full Text] [Related]
16. Myelodysplastic Syndrome and Sweet's Syndrome Are Associated with a Mutation in Isocitrate Dehydrogenase 1.
Snyder R; Libby T; Raciti P; Amin B; Jacobson M; Rakheja D; Fleming K; Bartenstein M; Zhu C; Goel S; Verma AK; Shastri A
Anticancer Res; 2018 Apr; 38(4):2201-2205. PubMed ID: 29599340
[TBL] [Abstract][Full Text] [Related]
17. IDH1 mutation detection by droplet digital PCR in glioma.
Wang J; Zhao YY; Li JF; Guo CC; Chen FR; Su HK; Zhao HF; Long YK; Shao JY; To Ss; Chen ZP
Oncotarget; 2015 Nov; 6(37):39651-60. PubMed ID: 26485760
[TBL] [Abstract][Full Text] [Related]
18. Nanofluidic Allele-Specific Digital PCR Method for Quantifying IDH1 and IDH2 Mutation Burden in Acute Myeloid Leukemia.
Wiseman DH; Somervaille TCP
Methods Mol Biol; 2017; 1633():235-255. PubMed ID: 28735491
[TBL] [Abstract][Full Text] [Related]
19. Genetic characterization of acute myeloid leukemia patients with mutations in IDH1/2 genes.
Acha P; Hoyos M; Pratcorona M; Fuster-Tormo F; Palomo L; Ortega E; Zamora L; Vives S; Granada I; Montoro J; Garcia A; Arnan M; Cervera M; Canet M; Gallardo D; Arenillas L; Esteve J; Baragay J; Salamero O; Motlló C; Ortín X; Sierra J; Solé F
Leuk Res; 2021 Feb; 101():106492. PubMed ID: 33494038
[No Abstract] [Full Text] [Related]
20. [IDH1/2 gene mutations in myelodysplastic syndromes].
Yoshida K; Sanada M; Ogawa S
Rinsho Ketsueki; 2012 Apr; 53(4):391-5. PubMed ID: 22687971
[No Abstract] [Full Text] [Related]
[Next] [New Search]